Cargando…
Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice
BACKGROUND: Recently, we found that the probiotic strain Bacillus coagulans GBI-30, 6086 (GanedenBC(30)) improved indices of Clostridium difficile (C. difficile)-induced colitis in mice (Fitzpatrick et al., Gut Pathogens, 2011). Our goal was to determine if BC30 could also prevent the recurrence of...
Autores principales: | Fitzpatrick, Leo R, Small, Jeffrey S, Greene, Wallace H, Karpa, Kelly D, Farmer, Sean, Keller, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484022/ https://www.ncbi.nlm.nih.gov/pubmed/23088680 http://dx.doi.org/10.1186/1757-4749-4-13 |
Ejemplares similares
-
Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice
por: Fitzpatrick, Leo R, et al.
Publicado: (2011) -
Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization
por: Jäger, Ralf, et al.
Publicado: (2017) -
Bacillus coagulans GBI-30, 6086 improves amino acid absorption from milk protein
por: Stecker, Richard A., et al.
Publicado: (2020) -
Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery
por: Jäger, Ralf, et al.
Publicado: (2016) -
Draft Genome Sequence of Bacillus coagulans GBI-30, 6086, a Widely Used Spore-Forming Probiotic Strain
por: Orrù, Luigi, et al.
Publicado: (2014)